WORLDWIDE HEALTHCARE: Trust focuses on pharma and biotech firms developing ground-breaking drugs
Worldwide Healthcare invests in medical companies across the globe
What is it?
The trust invests in medical companies across the globe. It is managed by Orbimed, the world’s largest specialist healthcare investor.
What does the manager invest in?
It mainly buys shares in pharmaceutical and biotechnology companies, and focuses on identifying those which are developing ground-breaking drugs.
Its largest holdings include Japan’s Takeda Pharmaceutical, medical devices firm Boston Scientific and gene therapy company Novartis.
What do the experts like?
With coronavirus causing global panic, healthcare firms are now in a position to benefit – if they can find treatments.
Laura Suter, personal finance analyst at AJ Bell, says: ‘The £1.6billion trust is run by a specialist healthcare asset manager, which includes a number of team members who have worked directly in the industry, meaning they have on-the-ground knowledge of the market.’
The trust is typically higher risk than many of its peers, as it targets smaller companies which are working on more experimental treatments.